Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 3 Neoplasms 2 Nausea 2 Solid Tumors 1 Prostatic Neoplasms 1 Polyps 1 Mouth Neoplasms 1 Lymphoma 1 Hypopharyngeal Neoplasms 1 Critical Illness 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Docetaxel 158 Prednisone 131 Leuprolide 95 bicalutamide 86 enzalutamide 83 Radiotherapy 80 Goserelin 80 Abiraterone Acetate 76 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54 Magnetic Resonance Spectroscopy 46 Zoledronic Acid 44 gallium 68 PSMA-11 37 Flutamide 34 abiraterone 32 Estramustine 32 radium Ra 223 dichloride 30 apalutamide 27 Surveys and Questionnaires 26 Gonadotropin-Releasing Hormone 26 Androgen Antagonists 25 cabazitaxel 24 Radiosurgery 24 Dutasteride 22 sipuleucel-T 21 Prednisolone 21 Triptorelin Pamoate 20 Paclitaxel 20 luprolide acetate gel depot 19 Radiation 19 Exercise 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Metoclopramide × Clear all

NCT02441894 2017-01-24

PEGAZUS

Sanofi

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡